title: Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset.
abstract: BACKGROUND
  The primary objective of this study was to determine if elevated antiphospholipid antibody titers were correlated with the presence of preeclampsia/eclampsia, systemic lupus erythematosus (SLE), placental insufficiency, and a prolonged length of stay (PLOS), in women who delivered throughout Florida, USA.
  
  
  METHODS
  Cross-sectional analyses were conducted using a statewide hospital database. Prevalence odds ratios (OR) were calculated to quantify the association between elevated antiphospholipid antibody titers and four outcomes in 141,286 women who delivered in Florida in 2001. The possibility that the relationship between elevated antiphospholipid antibody titers and the outcomes of preeclampsia/eclampsia, placental insufficiency, and PLOS, may have been modified by the presence of SLE was evaluated in a multiple logistic regression model by creating a composite interaction term.
  
  
  RESULTS
  Women with elevated antiphospholipid antibody titers (n = 88) were older, more likely to be of white race and not on Medicaid than women who did not have elevated antiphospholipid antibody titers. Women who had elevated antiphospholipid antibody titers had an increased adjusted odds ratio for preeclampsia and eclampsia, (OR = 2.93 p = 0.0015), SLE (OR = 61.24 p < 0.0001), placental insufficiency (OR = 4.58 p = 0.0003), and PLOS (OR = 3.93 p < 0.0001). Patients who had both an elevated antiphospholipid antibody titer and SLE were significantly more likely than the comparison group (women without an elevated titer who did not have SLE) to have the outcomes of preeclampsia, placental insufficiency and PLOS.
  
  
  CONCLUSIONS
  This exploratory epidemiologic investigation found moderate to very strong associations between elevated antiphospholipid antibody titers and four important outcomes in a large sample of women.
authors.affiliation: Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. jnodler@uab.edu
authors.forename: James
authors.initials: J
authors.lastname: Nodler
authors.forename: Surjit R
authors.initials: SR
authors.lastname: Moolamalla
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Ledger
authors.forename: Bahij S
authors.initials: BS
authors.lastname: Nuwayhid
authors.forename: Zuber D
authors.initials: ZD
authors.lastname: Mulla
mesh_terms: D000293:Adolescent; D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002648:Child; D004461:Eclampsia / Q000175:diagnosis / Q000276:immunology*; D005260:Female; D006801:Humans; D007902:Length of Stay; D008875:Middle Aged; D010927:Placental Insufficiency / Q000175:diagnosis / Q000276:immunology*; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000276:immunology; D011247:Pregnancy; D055815:Young Adult
chemical_list: D017152:Antibodies, Antiphospholipid